RE:RE:RE:RE:busy times here...Can't say I don't like the idea of a collaboration with Sigilion it would add yet another layer of validation not that we need it at this point. However it would come as a surprise as they have already started Recruiting for their FDA trials using the spheres. Each sphere contains thousands of cells it's not like they are just injecting cells. I don't get how the cells survive with out pre-vascularizing the spheres then dosing the islets after. The process of collecting and dosing a bunch of small spheres doesn't seem optimal so who knows maybe they see the writing on the wall and have approached Sernova.